{"retracted":false,"update":{"timestamp":1490054400000,"doi":"10.1007/s00198-017-4006-3","type":"correction"},"doi":"10.1007/s00198-017-3973-8","journal":"Osteoporosis International","publisher":"Springer Nature","title":"Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan"}
